tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.070USD
+0.040+3.88%
종가 02/06, 16:00ET시세는 15분 지연됩니다
5.64M시가총액
손실P/E TTM

STRATA Skin Sciences Inc

1.070
+0.040+3.88%

자세한 내용은 STRATA Skin Sciences Inc 회사

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Inc 정보

종목 코드 SSKN
회사 이름Strata Skin Sciences Inc
상장일Oct 28, 2005
CEORafaeli (Dolev)
직원 수106
유형Ordinary Share
회계 연도 종료Oct 28
주소5 Walnut Grove Drive, Suite 140
도시HORSHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호19044
전화12156193200
웹사이트https://www.strataskinsciences.com/
종목 코드 SSKN
상장일Oct 28, 2005
CEORafaeli (Dolev)

STRATA Skin Sciences Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-32960.00%
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-4675.00%
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-32960.00%
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-4675.00%
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States (Country)
5.22M
75.31%
Other foreign
939.00K
13.55%
Foreign
470.00K
6.78%
Middle East
172.00K
2.48%
China
130.00K
1.88%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
기타
51.60%
주주
주주
비율
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
기타
51.60%
주주 유형
주주
비율
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.60%
Hedge Fund
8.62%
Corporation
6.21%
Investment Advisor
0.85%
Individual Investor
0.18%
기타
50.06%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
39
2.56M
43.55%
-107.46K
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Accelmed Growth Partners Management Ltd
1.44M
24.49%
--
--
Sep 04, 2025
22NW, LP
537.00K
9.12%
--
--
Sep 30, 2025
Nantahala Capital Management, LLC
403.92K
6.86%
--
--
Sep 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.21%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
101.53K
1.72%
+3.50K
+3.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
18.14K
0.31%
-56.00
-0.31%
Sep 30, 2025
The Vanguard Group, Inc.
23.55K
0.4%
-61.09K
-72.18%
Sep 30, 2025
Susquehanna International Group, LLP
12.43K
0.21%
+12.43K
--
Sep 30, 2025
Rubinstein (Samuel)
10.77K
0.18%
-9.09K
-45.79%
Nov 18, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
날짜
배당락일
유형
비율
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI